Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03662126
Title KRT-232 in Subjects With PMF, Post-PV MF, or Post-ET MF Who Have Failed a JAK Inhibitor
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kartos Therapeutics, Inc.
Indications

myelofibrosis

Therapies

KRT-232

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.